There have been 50 recent insider transactions recorded for GlycoMimetics, Inc. (GLYC), including 36 buys and 14 sells. Total insider buying was valued at $6.73M and total insider selling at $1.54M.
Notable insiders with recent activity include Invus Public Equities, L.p., Siren, L.l.c., Rock Edwin. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — GLYC
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-08-08 |
Invus Public Equities, L.p. |
10 Percent Owner |
Informative Sell |
260,873 |
$0.19 |
$50.01K |
6,317,565 |
| 2024-08-07 |
Invus Public Equities, L.p. |
10 Percent Owner |
Informative Sell |
61,488 |
$0.18 |
$11.2K |
6,578,438 |
| 2024-08-06 |
Invus Public Equities, L.p. |
10 Percent Owner |
Informative Sell |
55,732 |
$0.18 |
$10.19K |
6,639,926 |
| 2024-08-05 |
Invus Public Equities, L.p. |
10 Percent Owner |
Informative Sell |
164,523 |
$0.19 |
$31K |
6,695,658 |
| 2024-08-02 |
Invus Public Equities, L.p. |
10 Percent Owner |
Informative Sell |
286,200 |
$0.20 |
$57.35K |
6,860,181 |
| 2024-08-01 |
Invus Public Equities, L.p. |
10 Percent Owner |
Informative Sell |
63,564 |
$0.22 |
$13.74K |
7,146,381 |
| 2024-07-30 |
Invus Public Equities, L.p. |
10 Percent Owner |
Informative Sell |
756,835 |
$0.22 |
$167.18K |
7,209,945 |
| 2024-07-29 |
Invus Public Equities, L.p. |
10 Percent Owner |
Informative Sell |
363,949 |
$0.24 |
$85.64K |
7,966,780 |
| 2024-07-26 |
Invus Public Equities, L.p. |
10 Percent Owner |
Informative Sell |
258,335 |
$0.24 |
$62.44K |
8,330,729 |
| 2024-07-25 |
Siren, L.l.c. |
10 Percent Owner |
Disposition |
- |
- |
- |
8,589,064 |
| 2024-06-21 |
Rock Edwin |
Chief Medical Officer |
Informative Buy |
115,000 |
$0.27 |
$30.72K |
680,403 |
| 2024-06-20 |
Rock Edwin |
Chief Medical Officer |
Informative Buy |
190,000 |
$0.25 |
$48.11K |
565,403 |
| 2024-06-18 |
Hahn Brian M. |
SVP Finance, CFO |
Informative Buy |
17,500 |
$0.25 |
$4.33K |
70,643 |
| 2024-05-01 |
Junius Daniel M |
Director |
RSU Award |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Andrews Patricia S |
Director |
RSU Award |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Pearson Timothy R |
Director |
RSU Award |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Goldberg Mark Alan |
Director |
RSU Award |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Jackson Scott Thomas |
Director |
RSU Award |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Koenig Scott |
Director |
RSU Award |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
King Rachel K. |
Director |
RSU Award |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-03-29 |
Junius Daniel M |
Director |
RSU Award |
5,209 |
$3.00 |
$15.63K |
98,459 |
| 2024-03-29 |
Goldberg Mark Alan |
Director |
RSU Award |
4,584 |
$3.00 |
$13.75K |
24,828 |
| 2024-03-29 |
King Rachel K. |
Director |
RSU Award |
3,334 |
$3.00 |
$10K |
515,194 |
| 2024-01-12 |
Hahn Brian M. |
SVP Finance, CFO |
RSU Award |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2024-01-12 |
Semerjian Harout |
Chief Executive Officer |
RSU Award |
695,000 |
$3.11 |
$2.16M |
695,000 |
| 2024-01-12 |
Rock Edwin |
Chief Medical Officer |
RSU Award |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2024-01-12 |
Rath Chinmaya |
SVP and Chief Business Officer |
RSU Award |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2024-01-12 |
Johnson Bruce S |
SVP & Chief Commercial Officer |
RSU Award |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2023-12-29 |
Andrews Patricia S |
Director |
RSU Award |
5,191 |
$2.36 |
$12.25K |
58,608 |
| 2023-12-29 |
Goldberg Mark Alan |
Director |
RSU Award |
5,827 |
$2.36 |
$13.75K |
20,244 |
| 2023-12-29 |
King Rachel K. |
Director |
RSU Award |
4,238 |
$2.36 |
$10K |
511,860 |
| 2023-09-30 |
Andrews Patricia S |
Director |
RSU Award |
8,167 |
$1.50 |
$12.25K |
53,417 |
| 2023-09-30 |
Goldberg Mark Alan |
Director |
RSU Award |
9,167 |
$1.50 |
$13.75K |
14,417 |
| 2023-09-30 |
King Rachel K. |
Director |
RSU Award |
6,667 |
$1.50 |
$10K |
507,622 |
| 2023-09-22 |
Rock Edwin |
Chief Medical Officer |
Informative Buy |
30,403 |
$1.38 |
$41.96K |
375,403 |
| 2023-09-21 |
Rock Edwin |
Chief Medical Officer |
Informative Buy |
35,000 |
$1.38 |
$48.3K |
345,000 |
| 2023-06-01 |
Koenig Scott |
Director |
Option Exercise (Sell) |
21,000 |
$0.60 |
$12.6K |
- |
| 2023-05-19 |
Junius Daniel M |
Director |
RSU Award |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Andrews Patricia S |
Director |
RSU Award |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Pearson Timothy R |
Director |
RSU Award |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Goldberg Mark Alan |
Director |
RSU Award |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Jackson Scott Thomas |
Director |
RSU Award |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Koenig Scott |
Director |
RSU Award |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
King Rachel K. |
Director |
RSU Award |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-17 |
Hahn Brian M. |
SVP Finance, CFO |
Informative Sell |
3,700 |
$1.95 |
$7.22K |
53,143 |
| 2023-05-10 |
Junius Daniel M |
Director |
Informative Buy |
30,000 |
$1.56 |
$46.8K |
93,250 |
| 2023-05-08 |
Johnson Bruce S |
SVP & Chief Commercial Officer |
Informative Buy |
13,500 |
$1.57 |
$21.2K |
138,980 |
| 2023-03-23 |
Rath Chinmaya |
SVP and Chief Business Officer |
Disposition |
150,000 |
$3.48 |
$522K |
- |
| 2023-03-23 |
Johnson Bruce S |
SVP & Chief Commercial Officer |
Disposition |
200,000 |
$2.55 |
$510K |
- |
| 2023-02-24 |
Invus Public Equities, L.p. |
10 Percent Owner |
Informative Buy |
100,000 |
$1.70 |
$170K |
8,589,064 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
